cmi_logo.png
[Latest] Global Hereditary Cancer Testing Market Size/Share Worth USD 12.1 Billion by 2033 at a 7.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
April 02, 2024 14:00 ET | Custom Market Insights
Austin, TX, USA, April 02, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Hereditary Cancer Testing Market Size, Trends and Insights By Disease Type...
RateLinx Logo
RateLinx Named in the 2021 Gartner Market Guide for Freight Audit and Payment Providers
August 17, 2021 09:00 ET | RateLinx
SCOTTSDALE, Ariz., Aug. 17, 2021 (GLOBE NEWSWIRE) -- Gartner, the world’s leading research and advisory company, recently named RateLinx to their latest Market Guide for Freight Audit and Payment...
Sucampo to Host 2017
Sucampo to Host 2017 R&D Day on November 16 in New York
November 09, 2017 17:48 ET | Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced that it will host its 2017 R&D Day...
Sucampo Reports Seco
Sucampo Reports Second Quarter 2017 Financial Results
August 02, 2017 06:30 ET | Sucampo Pharmaceuticals Inc
Patent Issued for Pipeline Compound VTS-270 for Niemann-Pick Disease Type C1 Diluted EPS Loss of $3.92 Resulting from $186.6M IP R&D Second Quarter Charge Due to Accounting Treatment of Vtesse...